Camp4 Therapeutics (CAMP) Accumulated Depreciation & Amortization (2023 - 2026)
Camp4 Therapeutics recorded quarterly Accumulated Depreciation & Amortization of $500000.0 in Q1 2026, down 68.75% quarter-over-quarter from $1.6 million in Q4 2025, and up 25.0% year-over-year from $400000.0 in Q1 2025.
Camp4 Therapeutics' Accumulated Depreciation & Amortization history runs 4 years deep, the most recent figure standing at $500000.0 for Q1 2026.
- In Q1 2026, Accumulated Depreciation & Amortization rose 25.0% year-over-year to $500000.0; the TTM figure through Mar 2026 stood at $500000.0 (up 25.0% YoY), while the FY2025 annual figure was $1.6 million, down 5.88% from the prior year.
- Accumulated Depreciation & Amortization came in at $500000.0 for Q1 2026 at Camp4 Therapeutics, down from $1.6 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.7 million in Q4 2024 to a low of $400000.0 in Q1 2025.
- A 4-year average of $999272.7 and a median of $900000.0 in 2024 frame the typical range for Accumulated Depreciation & Amortization.
- Across the five-year window, Accumulated Depreciation & Amortization sank 68.7% in 2025 and grew 25.0% in 2026, its largest moves.
- Camp4 Therapeutics' Accumulated Depreciation & Amortization stood at $1.7 million in 2023, then advanced by 1.31% to $1.7 million in 2024, then decreased by 5.88% to $1.6 million in 2025, then slumped by 68.75% to $500000.0 in 2026.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $500000.0, $1.6 million, and $400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 1.60 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 436,000.00 |
| Mar 31, 2024 | 436,000.00 |
| Dec 31, 2023 | 1.68 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |